Robotic Buccal Mucosa Graft Ureteroplasty: A Decade of Experience from a Multi-Institutional Cohort

Brian W. Chao,Michael Raver,Jeffery Lin,Kelley Zhao,Matthew Lee,Simon Gelman,Michael Stifelman,Lee C. Zhao,Daniel D. Eun
DOI: https://doi.org/10.1016/j.urology.2024.11.059
IF: 2.633
2024-12-02
Urology
Abstract:Objectives To characterize a large cohort of patients undergoing robotic buccal mucosa graft ureteroplasty (RU-BMG), determine the technique's durability, and assess the impact of patient- and disease-specific factors on outcomes. Methods We conducted a retrospective review of a multi-institutional database of robotic ureteral reconstruction for patients undergoing RU-BMG. Surgical success was defined as freedom from additional interventions for recurrent ureteral stenosis, such as stent placement, balloon dilation, or further attempts at reconstruction. Results 169 patients underwent RU-BMG over a 10-year period; of these, 163 met inclusion criteria for analysis. Median stricture length was 3.0 cm (IQR 2.0–4.0) and 77/163 (47.2%) patients had prior attempts at stricture treatment. Over a median follow-up duration of 29 months (12–56), 150/163 (92.0%) patients remained free from additional interventions. Median time to failure was 10.2 months (4.4–21.2). No factors were found to be independent predictors of surgical success, including stricture length, prior stricture treatment, or anastomotic technique. Limitations included a retrospective study design and low failure rate, which may have obscured the detection of statistically significant differences between groups. Conclusions In our updated multi-institutional series, RU-BMG retained excellent and durable surgical outcomes. RU-BMG should be considered as an initial management option for patients with ureteral strictures.
urology & nephrology
What problem does this paper attempt to address?